AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Global Dermatology Partnering Deal Trends, Players and Financials 2014-2019 - ResearchAndMarkets.com

March 25, 2019

DUBLIN--(BUSINESS WIRE)--Mar 25, 2019--The “Global Dermatology Partnering 2014-2019: Deal Trends, Players and Financials” report has been added to ResearchAndMarkets.com’s offering.

The Global Dermatology Partnering 2014-2019: Deal trends, players and financials report provides an understanding and access to the dermatology partnering deals and agreements entered into by the worlds leading healthcare companies.

Most of the deals included within the report occur when a licensee obtains a right or an option right to license a licensor’s product or technology. More often these days these deals tend to be multi-component including both a collaborative R&D and a commercialization of outcomes element.

The report takes readers through the comprehensive dermatology disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering Dermatology deals.

The report presents financial deal terms values for Dermatology deals, where available listing by overall headline values, upfront payments, milestones and royalties enabling readers to analyse and benchmark the value of current deals.

The initial chapters of this report provide an orientation of dermatology dealmaking trends.

Chapter 1 provides an introduction to the report.

Chapter 2 provides an overview of the trends in dermatology dealmaking since 2014 covering trends by year, deal type, stage of development, technology type and therapeutic indication.

Chapter 3 includes an analysis of financial deal terms covering headline value, upfront payment, milestone payments and royalty rates.

Chapter 4 provides a review of the leading dermatology deals since 2014. Deals are listed by headline value. The chapter includes the top 25 most active dermatology dealmakers, together with a full listing of deals to which they are a party. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.

Chapter 5 provides comprehensive access to dermatology deals since 2014 where a deal contract is available, providing the user with direct access to contracts as filed with the SEC regulatory authorities. Each deal title links via Weblink to an online version of the deal record contract document, providing easy access to each contract document on demand.

Chapter 6 provides a comprehensive directory of all dermatology partnering deals by specific dermatology target announced since 2014. The chapter is organized by specific dermatology therapeutic target. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

In addition, a comprehensive appendix is provided with each report of all dermatology partnering deals signed and announced since 2014. The appendices are organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc) and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The report also includes numerous tables and figures that illustrate the trends and activities in dermatology partnering and dealmaking since 2014.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of dermatology technologies and products.

Contract documents provide the answers to numerous questions about a prospective partner’s flexibility on a wide range of important issues, many of which will have a significant impact on each party’s ability to derive value from the deal.

Report Scope

Global Dermatology Partnering 2014-2019 includes:

  • Trends in dermatology dealmaking in the biopharma industry since 2014
  • Analysis of dermatology deal structure
  • Access to headline, upfront, milestone and royalty data
  • Access to over 700 dermatology deal records
  • The leading dermatology deals by value since 2014

Available deals are listed by:

  • Company A-Z
  • Headline value
  • Stage of development at signing
  • Deal component type
  • Specific therapy target

Key Topics Covered:

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in Dermatology dealmaking

2.1. Introduction

2.2. Dermatology partnering over the years

2.3. Dermatology partnering by deal type

2.4. Dermatology partnering by industry sector

2.5. Dermatology partnering by stage of development

2.6. Dermatology partnering by technology type

2.7. Dermatology partnering by therapeutic indication

Chapter 3 -Financial deal terms for Dermatology partnering

3.1. Introduction

3.2. Disclosed financials terms for Dermatology partnering

3.3. Dermatology partnering headline values

3.4. Dermatology deal upfront payments

3.5. Dermatology deal milestone payments

3.6. Dermatology royalty rates

Chapter 4 - Leading Dermatology deals and dealmakers

4.1. Introduction

4.2. Most active in Dermatology partnering

4.3. List of most active dealmakers in Dermatology

4.4. Top Dermatology deals by value

Chapter 5 - Dermatology contract document directory

5.1. Introduction

5.2. Dermatology partnering deals where contract document available

Chapter 6 - Dermatology dealmaking by therapeutic target

6.1. Introduction

6.2. Deals by Dermatology therapeutic target

Appendices

Appendix 1 - Directory of Dermatology deals by company A-Z 2014 to 2019

Appendix 2 - Directory of Dermatology deals by deal type 2014 to 2019

Appendix 3 - Directory of Dermatology deals by stage of development 2014 to 2019

Appendix 4 - Directory of Dermatology deals by technology type 2014 to 2019

For more information about this report visit https://www.researchandmarkets.com/research/tj8x6t/global?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20190325005417/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Dermatological Drugs

KEYWORD:

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 03/25/2019 08:44 AM/DISC: 03/25/2019 08:44 AM

http://www.businesswire.com/news/home/20190325005417/en